BayTech Venture Capital logo

BayTech Venture Capital

Europe, Bayern, Germany, München

Description

BayTech Venture Capital is a European Venture Capital firm.

Investor Profile

BayTech Venture Capital has made 23 investments, with 0 in the past 12 months and 26% as lead.

Stage Focus

  • Series B (43%)
  • Series Unknown (22%)
  • Series A (22%)
  • Series D (9%)
  • Series C (4%)

Country Focus

  • Germany (65%)
  • France (22%)
  • United States (9%)
  • Switzerland (4%)

Industry Focus

  • Software
  • Manufacturing
  • Mobile
  • Sensor
  • Wireless
  • Biotechnology
  • Health Care
  • Advertising
  • Genetics
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BayTech Venture Capital frequently co-invest with?

Wellington Partners
Europe, Bayern, Germany, Munich
Co-Investments: 5
Bioam Gestion
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Next47
North America, California, United States, Palo Alto
Co-Investments: 5
Emerald Technology Ventures
Europe, Zurich, Switzerland, Zürich
Co-Investments: 3
3i Group
Europe, England, United Kingdom, London
Co-Investments: 4
Target Partners
Europe, Bayern, Germany, Munich
Co-Investments: 2
Societe Generale Asset Management
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Global Life Science Ventures
Europe, Bayern, Germany, München
Co-Investments: 2
I-Source Gestion
Europe, Ile-de-France, France, Paris
Co-Investments: 2
CE
Europe, Ile-de-France, France, Paris
Co-Investments: 1

What are some of recent deals done by BayTech Venture Capital?

QuesCom

Valbonne, Provence-Alpes-Cote d'Azur, France

QuesCom designs and manufactures internet telecommunication systems such as business communication portals, GSM gateways, and more.

InternetManufacturingMobileWeb Hosting
Series UnknownJun 7, 2010
Amount Raised: $2,990,000
IntegraGen

Évry, Ile-de-France, France

IntegraGen is a biotechnology company developing molecular markers for central nervous system and metabolic diseases.

BiotechnologyGeneticsHealth CareTherapeutics
Series UnknownJun 6, 2010
EnOcean

Oberhaching, Bayern, Germany

EnOcean offers radio frequency communication and other wireless sensor solutions for use in buildings and industrial installations.

ManufacturingSensorWireless
Series UnknownDec 15, 2009
Amount Raised: $11,620,458
Ubidyne

Scottsdale, Arizona, United States

Ubidyne (Acquired by Kathrein 2013) develops dynamic active antenna technology, ASICS, software, and system-level architectures.

HardwareInformation TechnologySoftware
Series BAug 20, 2009
Amount Raised: $43,000,000
Inge Watertechnologies

Greifenberg, Bayern, Germany

Inge Watertechnologies develops ultrafilteration technology to treat drinking, processed, sea, and waste water.

Waste ManagementWaterWater Purification
Series UnknownJul 7, 2009
Amount Raised: $6,974,999
Open-Xchange

Köln, Nordrhein-Westfalen, Germany

Open-Xchange is committed to a borderless internet that is open, safe and free allowing users to protect their own data and privacy.

CollaborationEmailOpen SourceProductivity ToolsSoftware
Series BNov 4, 2008
Amount Raised: $9,000,000
EnOcean

Oberhaching, Bayern, Germany

EnOcean offers radio frequency communication and other wireless sensor solutions for use in buildings and industrial installations.

ManufacturingSensorWireless
Series DAug 19, 2008
Amount Raised: $6,637,746
ChipVision Design

Oldenburg In Holstein, Schleswig-Holstein, Germany

ChipVision Design Systems is a supplier of low-power system-level EDA software tools and services.

ElectronicsSemiconductorSoftware
Series BMay 16, 2008
Amount Raised: $4,671,158
Ads Click

Geneva, Geneve, Switzerland

Ads-Click is a provider of search and contextual advertising customized to suit advertisers' varying needs.

AdvertisingMobilePublishing
Series AMar 1, 2007
Amount Raised: $3,950,000
Pieris AG

Hallbergmoos, Bayern, Germany

Pieris Pharmaceuticals is a clinical-stage biotechnology company that develops drugs to fight cancer, severe asthma, anemia, and so on.

BiotechnologyHealth CareMedicalPharmaceutical
Series BNov 1, 2006
Amount Raised: $6,390,000